Loading
Kenvue Inc. Stock: price and insider trades · United States
US·Mcap US$34.2B
No insider purchase over the last 90 days. The latest was filed 15 Dec 2025.
Kenvue Inc.: what insiders have been doing
This page follows insider dealings at Kenvue Inc. as filed with SEC (Form 4) based in United States. Between 18 October 2025 and 18 October 2026, 12 insiders published 44 filings.
Every open-market trade in the period is a purchase: 1 purchase worth €47.3M, from 1 insider, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 senior executive among the declarants. One trade stands out by size: a purchase of €47.3M from Smith Jeffrey C, disclosed on 15 December 2025.
With 44 filings in twelve months, the company is more active than the median of 19 filings across the 5,808 companies we follow on the same exchange. Looking back to 2023, when coverage begins, insiders filed 3 purchases and 1 sale. The 10-K for the year ended 28 December 2025 shows 15.12 bn USD of revenue and 1.47 bn USD of net income and a dividend of 0.82 USD per share.
The latest purchase dates back some time: it was published 307 days ago, on 15 December 2025. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
120
Thresholds
n/a
Buy Volume
€48M
3 ops. · all time
Sell Volume
€361,753
1 ops. · all time
Who traded when
BuySaleCarlton Lawson1 sale
Smith Jeffrey C1 buy
Since the insiders bought
- +2.7%Entry US$17.25 · Close at T+90 US$17.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,239 of 24,148 companies
59.4
score / 100
Value53
Quality66
FCF yld4.8%
Earn yld4.1%
EV/EBITDA14.9x
ROE16%
Gross mgn58%
Net mgn9.7%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$17.83
Analyst consensus
12 analysts2.79/5
US$18.00Target US$19.50(+9%)US$23.00
Income statement
RevenueUS$15.1B
Gross profitUS$8.8B58% margin
EBITDAUS$3B20% margin
Net incomeUS$1.5B10.8% margin
Valuation
PER (trailing)20.7x
PER (forward)14.4x
P/Book3.2x
Beta0.45
Balance sheet & cash
Market capUS$34.2B
Total debtUS$8.7B
Free Cash FlowUS$1.7B
Debt / Equity82%
Profitability & ownership
ROE15.6%
ROA7.0%
% insiders0.1%
% institutions96.0%
Last declaration on 6 October 2026
Declarations120 total
36,597 shares@ US$17.200.0019% mcap60.8% of flowCommon StockSEC:0001944048-26-000158:0
35,754 shares@ US$17.200.0019% mcap70.8% of flowCommon StockSEC:0001944048-26-000157:0
14,749 shares@ US$17.200.0008% mcap29.2% of flowCommon StockSEC:0001944048-26-000157:1
35,754 shares@ US$17.200.0019% mcap68.2% of flowCommon StockSEC:0001944048-26-000156:0
15,192 shares@ US$17.200.0008% mcap29.0% of flowCommon StockSEC:0001944048-26-000156:1
24,732 shares@ US$17.200.0013% mcap74.5% of flowCommon StockSEC:0001944048-26-000155:0
8,471 shares@ US$17.200.0004% mcap25.5% of flowCommon StockSEC:0001944048-26-000155:1
10,881 shares@ US$17.200.0006% mcap53.8% of flowCommon StockSEC:0001944048-26-000154:0
5,566 shares@ US$17.200.0003% mcap27.5% of flowCommon StockSEC:0001944048-26-000154:1
66,028.99 sharesCommon StockSEC:0001944048-26-000148:0
21,031 shares@ US$17.220.0011% mcap100.0% of flowCommon StockSEC:0001944048-26-000148:1
429 shares@ US$17.810.0000% mcap29.4% of flowCommon StockSEC:0001944048-26-000146:1
429 sharesCommon StockSEC:0001944048-26-000146:0
1,032 sharesCommon StockSEC:0001944048-26-000146:2
1,032 shares@ US$17.810.0001% mcap70.6% of flowCommon StockSEC:0001944048-26-000146:3
16,418.87 shares0Common StockSEC:0001944048-26-000134:0
3,700 shares@ US$18.1050.0002% mcap100.0% of flowCommonSEC144:0001959173-26-004515
4,329.269 shares0Common StockSEC:0001944048-26-000070:0
3,525.293 shares0Common StockSEC:0001944048-26-000069:0
6,157.82 shares0Common StockSEC:0001944048-26-000068:0
7,736.17 shares0Common StockSEC:0001944048-26-000064:0
4,289.08 shares0Common StockSEC:0001944048-26-000063:0
6,178.21 shares0Common StockSEC:0001944048-26-000062:0
2,722.87 shares0Common StockSEC:0001944048-26-000061:0
1,534.48 shares0Common StockSEC:0001944048-26-000052:0
25 of 120 declarations
About Kenvue Inc.
Kenvue Inc. is a company listed on the XNAS market, specializing in consumer products. It offers a range of health and personal care products.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
